We are live on
!
Find out more
DCI
Data Collective IV Portfolio holdings
AUM
$55.9M
1-Year Est. Return
49.14%
This Fund
S&P 500
This Quarter
Est. Return
-13.61%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.2M
AUM Growth
-$31.3M
(-25%)
Cap. Flow
-$3.76M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roivant Sciences
ROIV
|
+$144K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFTX
Definium Therapeutics
DFTX
|
+$3.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.56% |
| 2 | Industrials | 40.44% |
| 3 | Technology | 11.01% |
Similar funds
BWA
JRCM
OFA
LCM
EI
CTFG
AA
CAM
Data Collective IV's Q4 2022 Portfolio in Review
As of Q4 2022, Data Collective IV held 6 positions worth $95.2M, down 25% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Data Collective IV withdrew a net $3.76M in Q4 2022, reducing 1 holding. Its largest reduction was Definium Therapeutics, cutting an estimated $3.9M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 54% a quarter earlier, followed by Industrials and Technology.
Against the trend, Data Collective IV opened a new position in Roivant Sciences worth $206K.
- Data Collective IV's largest Q4 2022 buy was Roivant Sciences: 25,840 shares worth $206K.
- Data Collective IV's biggest Q4 2022 reduction was Definium Therapeutics, cutting an estimated $3.9M.
- Data Collective IV's ten largest holdings make up 100% of its $95.2M portfolio in Q4 2022.
- Data Collective IV opened 1 new position and closed 0 in Q4 2022.
- Data Collective IV's portfolio value fell 25% quarter-over-quarter to $95.2M.
Based on Data Collective IV's 13F filing for Q4 2022, filed 14 Feb 2023.